Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • NPPA fixes retail...

    NPPA fixes retail price of 14 combo drugs including Aspirin, Paracetamol, Vitamin D3; Details

    Farhat NasimWritten by Farhat Nasim Published On 2019-06-27T16:07:01+05:30  |  Updated On 16 Aug 2021 12:17 PM IST

    New Delhi: Through a recent notification, the government regulatory agency, the National Pharmaceutical Pricing Authority (NPPA) has fixed the retail price of 14 drug formulations under the Drugs Prices Control Order (DPCO), 2013 exclusive of goods and services tax (GST).


    The drugs whose price have been fixed by NPPA include Atorvastatin, Vitamin D3 Tablet, Rosuvastatin, Aspirin, Paracetamol in combination with other formulations. Some of the combinations are Paracetamol + Mefenamic Acid Suspension; Clopidogrel + Aspirin Tablet; Atorvastatin + Vitamin D3 Tablet; Metoprolol+ + Amlodipine Tablet and so on.


    Notable drugmakers namely, Sun Pharmaceuticals Ltd (Sun Pharma), Intas Pharma, Cipla, Abbott, Mylan and others are responsible for manufacturing these widely used formulations.


    Combination of Atorvastatin + Vitamin D3 Tablet manufactured by Sun Pharma is sold under the brand name Daztor. The product is indicated for the treatment of high cholesterol.


    While another popular combination of Paracetamol + Mefenamic Acid Suspension manufactured and marketed under the brand name Mifucet by Intas Pharma is used for pain relief and treating fever.


    The list also reads Sun Pharma's combination drug Clopidogrel + Aspirin Tablet sold as Clopilet A 75 Capsule which is used for the treatment of angina pectoris (chest discomfort/pain caused due to insufficient oxygen supply to the heart muscle), heart attack, and stroke (a medical condition caused by insufficient blood flow and oxygen supply to the brain).


    The details of the list of all 14 formulations read;






































































































































    Sl.

    No.
    Name of the

    Formulation / Brand Name
    StrengthUnitManufacturer & Marketing CompanyRetail

    Price (Rs.)
    (1)(2)(3)(4)(5)(6)
    1.Tacrolimus Ointment (MYLIMUS 0.1%

    10gm)
    Each gm of Ointment contains: Tacrolimus IP 1mg (10gm pack)

    1gm
    M/s Alina Healthcare Pvt. Ltd. / M/s Mylan Pharmaceuticals Private

    Limited
    30.89
    2.Tacrolimus Ointment (MYLIMUS 0.1%

    20gm)
    Each gm of Ointment contains: Tacrolimus IP 1mg (20gm pack)

    1gm
    M/s Alina Healthcare Pvt. Ltd. / M/s Mylan

    Pharmaceuticals Private Limited
    30.89
    3.Amoxycillin + Potassium Clavulanate SuspensionEach 5ml of reconstituted suspension contains:

    Amoxycillin Trihydarte IP eq. to Amoxycillin 400mg,

    Potassium Clavulanate Diluted IP eq. to Clavulanic acid 57mg




    1 ML


    M/s Brooks Laboratories Ltd. / M/s Intas Pharmaceuticals Limited
    3.28
    4.Metoprolol+

    + Amlodipine Tablet
    Each film coated tablet contains: Metoprolol Succinate IP 23.75mg eq. to Metoprolol Tartrate 25mg, (as prolonged release form),

    Amlodipine Besylate IP eq. to

    Amlodipine 5mg.




    1 Tablet


    M/s Windlas Biotech Limited / M/s Abbott Healthcare Pvt. Ltd.
    5.58
    5.Atorvastatin + Clopidogrel CapsuleEach hard gelatine capsule contains: Atorvastatin Calcium IP eq. to Atorvastatin 20mg (As Pellets), Clopidogrel Bisulphate IP eq. to Clopidogrel 75mg (As Pellets)



    1 Capsule


    M/s Synokem Pharmaceuticals Ltd. / M/s Cipla Limited
    16.73
    6.Atorvastatin + Vitamin D3 TabletEach film coated tablet contains: Atorvastatin Calcium IP eq. to

    Atorvastatin 10mg

    Vitamin D3 (Cholecalciferol) IP 1000 IU


    1 Tablet
    M/s Sun Pharma Laboratories Limited9.18
    7.Atorvastatin + Vitamin D3 TabletEach film coated tablet contains: Atorvastatin Calcium IP eq. to Atorvastatin 20mg

    Vitamin D3 (Cholecalciferol) IP 1000 IU


    1 Tablet


    M/s Sun Pharma Laboratories Limited
    16.12
    8.Olmesartan Medoxomil + Amlodipine + Chlorthalidone TabletEach film coated tablet contains: Olmesartan Medoxomil IP 20mg Amlodipine Besylate IP eq. to Amlodipine 5mg

    Chlorthalidone IP 12.5mg




    1 Tablet


    M/s Sun Pharma Laboratories Limited
    9.65
    9.Olmesartan Medoxomil + Amlodipine + Chlorthalidone TabletEach film coated tablet contains: Olmesartan Medoxomil IP 40mg, Amlodipine Besylate IP eq. to Amlodipine 5mg

    Chlorthalidone IP 12.5mg




    1 Tablet


    M/s Sun Pharma Laboratories Limited
    15.83
    10.Rosuvastatin + Aspirin + Clopidogrel CapsuleEach hard gelatin capsule contains: Rosuvastatin Calcium IP eq. to Rosuvastatin 10mg (As Film coated Tablet),

    Aspirin IP 75mg (As Aspirin Gastro – resistant Tablets)

    Clopidogrel Bisulphate IP eq. to

    Clopidogrel 75mg (As film coated tablet)






    1 Capsule




    M/s Akums Drugs & Pharmaceuticals Limited

    / M/s Intas Pharmaceuticals Limited
    11.15
    11.Rosuvastatin + Aspirin + Clopidogrel CapsuleEach hard gelatin capsule contains: Rosuvastatin Calcium IP eq. to Rosuvastatin 20mg (As Film coated Tablet),

    Aspirin IP 75mg (As Aspirin Gastro – resistant Tablets)

    Clopidogrel Bisulphate IP eq. to

    Clopidogrel 75mg (As film coated tablet)






    1 Capsule




    M/s Akums Drugs & Pharmaceuticals Limited

    / M/s Intas Pharmaceuticals Limited
    16.82
    12.Paracetamol + Mefenamic Acid SuspensionEach 5ml Suspension contains: Paracetamol IP 250mg Mefenamic Acid IP 100mg

    1 ML
    M/s Tirupati Medicare Limited / M/s Intas Pharmaceuticals Limited0.63
    13.Clopidogrel + Aspirin TabletEach film coated tablet contains: Clopidogrel Bisulphate IP eq. to Clopidogrel 75mg

    Aspirin IP (As enteric coated) 75mg


    1 Tablet


    M/s Sun Pharma Laboratories Limited
    3.48
    14.Clopidogrel + Aspirin TabletEach film coated tablet contains: Clopidogrel Bisulphate IP eq. to Clopidogrel 75mg

    Aspirin IP (As enteric coated) 150mg


    1 Tablet


    M/s Sun Pharma Laboratories Limited
    3.55

    The NPPA notice further adds;




    • The manufacturer of above-mentioned formulations i.e. "new drug" under paragraph 2(u) of the DPCO, 2013 shall fix the retail price as specified in column (6) of the table hereinabove.

    • The manufacturer may add goods and services tax only if they have paid actually or it is payable to the Government on the retail price mentioned in column (6) of the above-said table.

    • The retail price for a pack of the aforesaid formulation shall be arrived at by the concerned manufacturer in accordance with the retail price specified in column (6) of the above table as per provisions contained in paragraph 11 of the DPCO, 2013. The manufacturer shall issue a price list in Form–V from date of Notification as per paragraph 24 of the DPCO, 2013 to NPPA through IPDMS and submit a copy to State Drug Controller and dealers.

    • As per para 24(4) of DPCO 2013, every retailer and dealer shall display price list and the supplementary price list, if any, as furnished by the manufacturer, on a conspicuous part of the premises where he carries on business in a manner so as to be easily accessible to any person wishing to consult the same.

    • The above mentioned retail price is applicable only to the individual manufacturer / marketer as mentioned above i.e. who have applied for the same by submitting Form-I for price fixation / revision as stipulated under DPCO, 2013 and subject to fulfilment of all the applicable statutory requirements as laid down by the Govt. under relevant statutes/ rules, including manufacturing license permission from the Competent Authority i.e. the Central/State Licensing Authority, as may be applicable, by the concerned manufacturer/marketing companies.

    • In case the retail price of any of the aforesaid formulations is not complied with, as per instant price notification and notes specified hereinabove, then the concerned manufacturer/marketing company shall be liable to deposit the overcharged amount along with the interest thereon under the provisions of the DPCO, 2013 read with the Essential Commodities Act, 1955.

    • Consequent to the issue of ceiling price of such formulation as specified in column (2) of the above table in this notification, the price order(s) fixing ceiling or retail price, if any, issued prior to the above said date of notification, stand(s) superseded.


    Also Read: NPPA fixes retail price of 18 commonly used formulations including Metformin, Atorvastatin; Details

    Abbottanti-plateletsAspirinAtorvastatinCiplaclopidogrelClopilet A 75 CapsuleDaztorfever drughigh cholesterolIntas PharmaMifucetMylanNPPAOlmesartan medoxomilpainkillerParacetamolretail priceSun PharmaVitamin DVitamin D3

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Farhat Nasim
    Farhat Nasim

      Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751 To know about our editorial team click here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok